rs745844469
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_001286044.2(ACADM):c.-65A>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,612,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001286044.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACADM | NM_000016.6 | c.503A>C | p.Asp168Ala | missense_variant | 7/12 | ENST00000370841.9 | NP_000007.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACADM | ENST00000370841.9 | c.503A>C | p.Asp168Ala | missense_variant | 7/12 | 1 | NM_000016.6 | ENSP00000359878.5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251296Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135856
GnomAD4 exome AF: 0.00000959 AC: 14AN: 1460604Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726678
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74364
ClinVar
Submissions by phenotype
Medium-chain acyl-coenzyme A dehydrogenase deficiency Pathogenic:2Uncertain:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 22, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 28, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 168 of the ACADM protein (p.Asp168Ala). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Asp168 amino acid residue in ACADM. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23829193; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACADM protein function. ClinVar contains an entry for this variant (Variation ID: 226072). This missense change has been observed in individual(s) with clinical features of medium-chain acyl-coenzyme A dehydrogenase deficiency (PMID: 21083904; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs745844469, gnomAD 0.002%). - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 20, 2015 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Counsyl | May 02, 2017 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 09, 2023 | Reported previously in infants with a positive newborn screen for medium chain acyl-CoA dehydrogenase (MCAD) deficiency who were also heterozygous for the common p.(K329E) pathogenic variant, although the phase of these variants was not determined (PMID: 21083904, 23543005); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23543005, 35629059, 35281663, 21083904) - |
ACADM-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 10, 2024 | The ACADM c.503A>C variant is predicted to result in the amino acid substitution p.Asp168Ala. This variant was reported in the compound heterozygous state with the common pathogenic c.985A>G variant in a single medium chain acyl-CoA deficiency (MCADD) patient (Kennedy et al. 2010. PubMed ID: 21083904). Notably, a different substitution of the same amino acid (c.503A>T, p.Asp168Val) in trans (on the opposite allele) with the pathogenic c.985A>G variant has also been identified in one MCADD patient (Ventura et al. 2014. PubMed ID: 23829193). Additionally, we have observed the c.503A>C (p.Asp168Ala) variant along with a second pathogenic ACADM variant in several patients with suspected MCADD, and in one of the individuals it was proven by family studies to be in trans with the other ACADM variant (PreventionGenetics internal data). The c.503A>C variant has only been observed in only 4 of ~251,000 alleles (0.0016%), indicating it is a rare variant (http://gnomad.broadinstitute.org/variant/1-76205699-A-C). Based on these observations, this variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at